Parameter
| Biomarker | 5-MTP | Full name | 5-Methoxytryptophan | Molecular Type | Metabolites |
|---|---|---|---|---|---|
| Molecular Formula | C₁₂H₁₄N₂O₃ | Molecular Weight | 234.25 g/mol | Core Functional Dimensions | Early screening, Risk stratification |
| Disease | Chronic Kidney Disease (CKD) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Urine ( mass spectrometry, proteomics detection ) | ||
| Pathobiological Mechanisms | Regulating inflammation and fibrosis pathways, abnormal levels are associated with CKD progression | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Inhibiting NF-κB pathway can improve CKD-induced cerebrovascular injury, which has the potential of biomarkers and therapeutic targets. | ||||